Yudha Nurhantari

Title: Yudha Nurhantari: Innovator in Metalloprotease Research

Introduction

Yudha Nurhantari is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of metalloprotease proteins. His work focuses on the treatment and prevention of conformational diseases, showcasing his commitment to advancing medical science.

Latest Patents

Yudha holds a patent for a "Membrane-bound metalloprotease and soluble secreted form thereof." This invention discloses metalloprotease proteins or their salts that are usable for the treatment or prophylaxis of conformational diseases. Additionally, it provides a screening kit for the selection of carcinostatics and anti-metastatic agents. The metalloprotease proteins have an amino acid sequence set forth under SEQ ID NO:1 or NO:2 in the Sequence Listing. These proteins exhibit a neutral optimal pH and are capable of hydrolyzing endothelin 1, atrial natriuretic peptide, and angiotensin I. They are inhibited by 1,10-phenanthroline, phosphoramidon, and thiorphan. Yudha has 1 patent to his name.

Career Highlights

Throughout his career, Yudha has demonstrated a strong dedication to research and innovation. His work has not only contributed to scientific knowledge but also holds potential for practical applications in medicine. His expertise in metalloprotease proteins positions him as a valuable asset in the field of biochemistry.

Collaborations

Yudha has collaborated with notable colleagues, including Mitsuhiro Yokoyama and Sunu Budhi Raharjo. These partnerships have likely enhanced his research efforts and contributed to the success of his innovations.

Conclusion

Yudha Nurhantari is a distinguished inventor whose work in metalloprotease research has the potential to impact the treatment of various diseases. His innovative spirit and dedication to science continue to inspire advancements in the field.